Want to see SEER full AI Analyst Report?
SEER Stock Chart & Stats
$1.97
-$0.08(-3.90%)
At close: 4:00 PM EDT
$1.97
-$0.08(-3.90%)
Day’s Range― - ―
52-Week Range$1.55 - $2.41
Previous CloseN/A
Volume521.92K
Average Volume (3M)113.15K
Market Cap
$111.85M
Enterprise Value-$38.89
Total Cash (Recent Filing)$152.85M
Total Debt (Recent Filing)$22.39M
Price to Earnings (P/E)―
Beta1.37
Next Earnings
Nov 10, 2026EPS Estimate
-0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.22
Shares Outstanding55,372,017
10 Day Avg. Volume70,395
30 Day Avg. Volume113,152
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)0.41
Price to Sales (P/S)6.52
P/FCF Ratio-2.27
Enterprise Value/Market Cap>-0.01
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$4.00Price Target Upside103.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-1.1
Revenue Forecast (FY)$16.12M
Bulls Say, Bears Say
Bulls Say
Scientific Validation And Intellectual PropertyThird-party publications, comparative studies and a broad patent portfolio strengthen platform credibility and help defend Seer’s differentiation. These assets can support adoption, licensing opportunities and competitive protection over the medium term.
Strong Liquidity And Conservative LeverageA substantial cash balance and limited debt provide financial flexibility to fund research, commercial expansion and customer evaluations without heavy near-term borrowing. Management believes liquidity is sufficient to reach cash-flow breakeven, although burn remains material.
Improved Gross Margin And Emerging Commercial TractionImproved gross economics and sequential revenue growth suggest progress in monetizing the Proteograph platform. Increased instrument utilization, consumable pull-through and services could create a more recurring revenue mix if placements and customer adoption continue.
Bears Say
Severe Operating Losses And Persistent Cash BurnThe current revenue base is insufficient to support the cost structure, leaving Seer dependent on its cash reserves and potentially external capital. Continued losses reduce balance-sheet strength over time and make sustainable self-funding dependent on substantial operating improvement.
Weak Revenue Growth And Funding-driven Sales DelaysRevenue contraction and modest guidance indicate that adoption remains uneven rather than demonstrating a durable scaling trajectory. Academic and government funding pressure, grant delays and prolonged evaluations can extend sales cycles and limit near-term platform utilization.
High Operating Costs And Variable Gross MarginsOperating expenses remain several times larger than quarterly revenue, keeping the business far from profitability. Margin variability across instruments, consumables and services also makes future earnings quality uncertain until scale and the targeted 70–75% margin profile are achieved.
Seer News
SEER FAQ
What was Seer’s price range in the past 12 months?
Seer lowest stock price was $1.55 and its highest was $2.41 in the past 12 months.
What is Seer’s market cap?
Seer’s market cap is $111.85M.
When is Seer’s upcoming earnings report date?
Seer’s upcoming earnings report date is Nov 10, 2026 which is in 79 days.
How were Seer’s earnings last quarter?
Seer released its earnings results on Aug 11, 2026. The company reported -$0.31 earnings per share for the quarter, missing the consensus estimate of -$0.27 by -$0.04.
Is Seer overvalued?
According to Wall Street analysts Seer’s price is currently Undervalued.
Does Seer pay dividends?
Seer does not currently pay dividends.
What is Seer’s EPS estimate?
Seer’s EPS estimate is -0.26.
How many shares outstanding does Seer have?
Seer has 55,372,017 shares outstanding.
What happened to Seer’s price movement after its last earnings report?
Seer reported an EPS of -$0.31 in its last earnings report, missing expectations of -$0.27. Following the earnings report the stock price went down -0.926%.
Which hedge fund is a major shareholder of Seer?
Currently, no hedge funds are holding shares in SEER
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Seer Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (103.05% Upside)
$4.00 (103.05% Upside)
Hedge Fund Trend
Decreased
By 15.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $27.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
11.34%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-20.42%
Trailing 12-Months
Company Description
Seer
null
SEER Company Deck
SEER Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented strong scientific, IP and strategic positives — including substantial publication momentum, independent study validation, a robust patent position, healthy cash reserves and sequential revenue improvement — but these were tempered by meaningful near-term commercial and financial challenges: year-over-year revenue decline (~24%), ongoing net losses, negative free cash flow, funding headwinds in the academic market and only modest full-year guidance (~3% growth at midpoint). The message is one of long-term conviction in the technology coupled with a cautious near-term commercial outlook.View all SEER earnings summariesSEER Stock 12 Month Forecast
Average Price Target
$4.00
▲(103.05% Upside)
Technical Analysis
Inhibikase Therapeutics
―
Surrozen
―
Instil Bio
―
TScan Therapeutics
―
Cognition Therapeutics
―
Ownership Overview
13.75% Insiders
6.18% Mutual Funds
19.53% Other Institutional Investors
56.90% Public Companies and
Individual Investors